Renal Cancer - Results from #1060

Construction of a prognostic prediction model for renal clear cell carcinoma combining clinical traits. March 1, 2023

A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma. February 28, 2023

Stereotactic body radiation therapy to the kidney for metastatic renal cell carcinoma: A narrative review of an emerging concept. February 28, 2023

The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis. February 27, 2023

Cause-specific mortality among patients with renal cell carcinoma in the United States from 2000 to 2018. February 27, 2023

Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma. February 24, 2023

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO). February 24, 2023

Morbidity and mortality of multivisceral resection with radical nephrectomy for locally advanced renal cell carcinoma: An analysis of the National Surgical Quality Improvement Program (NSQIP) database. February 23, 2023

Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma. February 23, 2023

Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma. February 22, 2023

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. February 22, 2023

The association of healthy lifestyle index score and the risk of renal cell cancer in the Netherlands cohort study. February 21, 2023

Cost Effectiveness of Treatment Sequences in Advanced Renal Cell Carcinoma. February 21, 2023

Mitochondrial metabolism in primary and metastatic human kidney cancers. February 21, 2023

Urine supernatant reveals a signature that predicts survival in clear cell renal cell carcinoma. February 20, 2023

Thermal ablation vs. active surveillance for renal masses: a systematic review and network meta-analysis. February 20, 2023

Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma. February 17, 2023

NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma. February 17, 2023

Complete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients' Outcomes? February 16, 2023

Clear Cell Renal Cell Carcinoma: From Biology to Treatment. February 16, 2023

Page 54 of 456